| 1 |
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
Yoshinobu Kanda · Bone Marrow Transplantation
Open access |
3 Dec 2012 |
19,316 |
| 2 |
Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
Marc C. Hochberg · Arthritis & Rheumatism
|
Sep 1997 |
11,602 |
| 3 |
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh et al. · Nature
|
Feb 2000 |
10,021 |
| 4 |
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Richard Peto, M. C. Pike, P. Armitage et al. · British Journal of Cancer
Open access |
1977 |
8,414 |
| 5 |
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow, Elı́as Campo, Stefano Aldo Pileri et al. · Blood
Open access |
15 Mar 2016 |
7,935 |
| 6 |
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
NL Harris, ES Jaffe, H Stein et al. · Blood
Open access |
Sep 1994 |
6,356 |
| 7 |
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva Swarup Neelapu et al. · New England Journal of Medicine
Open access |
10 Dec 2017 |
6,098 |
| 8 |
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Yuan Chang, Ethel Cesarman, Melissa S. Pessin et al. · Science
|
16 Dec 1994 |
5,746 |
| 9 |
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson, Richard I. Fisher, Sally Fiona Barrington et al. · Journal of Clinical Oncology
Open access |
11 Aug 2014 |
5,725 |
| 10 |
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine
Open access |
24 Jan 2002 |
5,630 |
| 11 |
Revised Response Criteria for Malignant Lymphoma
Bruce D. Cheson, Beate Pfistner, Malik Eid Juweid et al. · Journal of Clinical Oncology
Open access |
22 Jan 2007 |
4,468 |
| 12 |
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Christine P. Hans · Blood
Open access |
22 Sep 2003 |
4,323 |
| 13 |
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio et al. · Leukemia
Open access |
22 Jun 2022 |
4,010 |
| 14 |
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
Andreas Rosenwald et al. · New England Journal of Medicine
Open access |
20 Jun 2002 |
3,883 |
| 15 |
WHO-EORTC classification for cutaneous lymphomas
Rein Willemze · Blood
Open access |
3 Feb 2005 |
3,826 |
| 16 |
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
Michael J. Hallek, Bruce D. Cheson, Daniel Catovsky et al. · Blood
Open access |
23 Jan 2008 |
3,806 |
| 17 |
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen Maxted Ansell, Alexander M. Lesokhin, Ivan Borrello et al. · New England Journal of Medicine
Open access |
6 Dec 2014 |
3,594 |
| 18 |
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Bruce D. Cheson, Sandra J. Horning, Bertr Coiffier et al. · Journal of Clinical Oncology
|
Apr 1999 |
3,495 |
| 19 |
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
David Lawrence Vaux, Suzanne Cory, Jerry M. Adams · Nature
|
Sep 1988 |
3,258 |
| 20 |
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson, Rachel A. O’Keefe, Jennifer Rubin Grandis · Nature Reviews Clinical Oncology
ReviewOpen access |
6 Feb 2018 |
3,257 |
| 21 |
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
Jacques J. M. van Dongen et al. · Leukemia
Open access |
Dec 2003 |
3,072 |
| 22 |
A review of human carcinogens—Part B: biological agents
Véronique Bouvard, Robert A. Baan, Kurt Straíf et al. · The Lancet Oncology
|
31 Mar 2009 |
2,976 |
| 23 |
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al. · Blood
Open access |
29 Jun 2022 |
2,906 |
| 24 |
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
Ethel Cesarman, Yuan Chang, Patrick S. Moore et al. · New England Journal of Medicine
Open access |
4 May 1995 |
2,885 |
| 25 |
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Peter Joseph McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology
|
Aug 1998 |
2,774 |
| 26 |
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
Steven A. Rosenberg, Michael T. Lotze, Linda Mesler Muul et al. · New England Journal of Medicine
|
9 Apr 1987 |
2,769 |
| 27 |
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park, Isabelle Rivière, Mithat Gönen et al. · New England Journal of Medicine
Open access |
31 Jan 2018 |
2,736 |
| 28 |
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
Rajendra N. Damle, Tarun Wasil, Franco Fais et al. · Blood
|
15 Sep 1999 |
2,607 |
| 29 |
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Lesley Seymour, Jan Bogaerts, Andrea Marie Perrone et al. · The Lancet Oncology
Open access |
Mar 2017 |
2,506 |
| 30 |
Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).
Michael Loran Dustin, Robert Rothlein, A K Bhan et al. · The Journal of Immunology
|
Jul 1986 |
2,474 |
| 31 |
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
Margaret Ann Shipp, Ken N. Ross, Pablo Tamayo et al. · Nature Medicine
|
2002 |
2,460 |
| 32 |
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
Thierry O. Philip, Cesare Guglielmi, Anton Hagenbeek et al. · New England Journal of Medicine
|
7 Dec 1995 |
2,458 |
| 33 |
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
Stephan Wade Morris, Mark N. Kirstein, Marcus B. Valentine et al. · Science
|
4 Mar 1994 |
2,424 |
| 34 |
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S Abramson et al. · The Lancet
|
Sep 2020 |
2,422 |
| 35 |
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
Lorena Appio, Carlo Landoni, Maria La Targia et al. · Chemotherapy
|
2017 |
2,332 |
| 36 |
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
Roland P. H. Schmitz et al. · New England Journal of Medicine
Open access |
11 Apr 2018 |
2,325 |
| 37 |
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
Christine L. Carter, Carol Allen, Donald Earl Henson · Cancer
Open access |
1989 |
2,314 |
| 38 |
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
Frederick Lundry Locke et al. · The Lancet Oncology
Open access |
2 Dec 2018 |
2,307 |
| 39 |
Occurrence and prognosis of extranodal lymphomas
C.R. Freeman, John W. Berg, Sidney J. Cutler · Cancer
|
1972 |
2,304 |
| 40 |
Epstein–Barr virus: 40 years on
Lawrence S. Young, Alan B. Rickinson · Nature reviews. Cancer
Review |
Oct 2004 |
2,248 |
| 41 |
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al. · New England Journal of Medicine
Open access |
5 Feb 2020 |
2,218 |
| 42 |
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments]
Jean Pierre Soulier, Laurence Grollet, Éric Oksenhendler et al. · Blood
|
15 Aug 1995 |
2,200 |
| 43 |
The World Health Organization (WHO) classification of the myeloid neoplasms
James W. Vardiman, Nancy L. Harris, Richard D. Brunning · Blood
|
18 Sep 2002 |
2,197 |
| 44 |
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Robert C. Bast, Thomas L. Klug, Elena St. John et al. · New England Journal of Medicine
|
13 Oct 1983 |
2,196 |
| 45 |
Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
Richard I. Fisher, Ellen R. Gaynor, Steve Dahlberg et al. · New England Journal of Medicine
Open access |
8 Apr 1993 |
2,167 |
| 46 |
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Cameron John Turtle et al. · Journal of Clinical Investigation
Open access |
24 Apr 2016 |
2,148 |
| 47 |
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
AC Wotherspoon, Tim C. Diss, Lang Pan et al. · The Lancet
|
Sep 1993 |
2,138 |
| 48 |
International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
International T-Cell Lymphoma Project · Journal of Clinical Oncology
|
14 Jul 2008 |
2,119 |
| 49 |
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael G. Pfreundschuh et al. · The Lancet Oncology
|
7 Apr 2006 |
2,098 |
| 50 |
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Richard J. Baer, Alan T. Bankier, Mark D. Biggin et al. · Nature
|
Jul 1984 |
2,069 |